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Objective.Todescribetheclinical,radiologicalandpathologicalﬁndingsinapatientwithmethadone-induceddelayedposthypoxic
encephalopathy (DPHE). Case Report. A Thirty-eight-year-old man was found unconscious for an unknown duration after
methadone and diazepam ingestion. His initial vitals were temperature 104 degree Fahrenheit, heart rate 148/minute, respiratory
rate 50/minute, and blood pressure 107/72mmhg. He developed renal failure, rhabdomyolysis, and elevated liver enzymes which
resolved completely in 6 days. After 2 weeks from discharge he had progressive deterioration of his cognitive, behavioral and
neurological function. Brain MRI showed diﬀuse abnormal T2 signal in the corona radiata, centrum semiovale, and subcortical
white matter throughout all lobes. Extensive work up was negative for any metabolic, infectious or autoimmune disorder. Brain
biopsy showed signiﬁcant axonal injury in the white matter. He was treated successfully with combination of steroids and
antioxidants. Follow up at 2 year showed no residual deﬁcits. Conclusion. Our observation suggests that patients on methadone
therapy should be monitored for any neurological or psychiatric symptoms, and in suspected cases MRI brain may help to make
the diagnosis of DPHE. A trial of steroids and antioxidants may be considered in these patients.
1.Introduction
Delayed posthypoxic encephalopathy (DPHE) is a rare
clinical entity characterized by delayed neurological deﬁcits
seen after an initial hypoxic-ischemic insult. It is commonly
described in relation to carbon monoxide (CO) poisoning
with prevalence of 0.06%–2.8% and equal sex predilection
[1]. Prognosis can be variable, ranging from complete
recovery to death. Methadone-induced DPHE is very rare
and has been reported in only 5 cases so far: 4 children and 1
adult[2–6].Wereportclinical,radiological,andpathological
ﬁndings of methadone induced DPHE in a 38-year-old man
who was successfully treated with methylprednisolone.
2.CaseReport
A 38-year-old righthanded Caucasian male computer engi-
neer presented to the Kansas University Medical Center
emergency department (ED) after being unconscious for
an unknown duration. His history was notable for prior
back and neck pain, for which he had taken methadone
and diazepam, prescribed for his father. He had a long
history of alcohol abuse, smoking, and hypertension. He had
no drug allergies. Family history was notable for a father
with schizophrenia, depression, and stimulant abuse. He
was unresponsive and comatose on initial examination. His
pupils were small (2mm) and reactive. All four extremities
moved in response to painful stimuli, and plantar responses
were bilaterally downgoing. He had right basal crackles.
His initial vital signs showed a temperature of 104 degree
Fahrenheit, heart rate of 148 beats/minute, a respiratory rate
of 50/minute, and blood pressure of 107/72mmhg. Patient
did not undergo any cardiopulmonary resuscitation and
was intubated for airway protection. Postintubation ABG
showed pH 7.4 (reference range (RR): 7.35–7.45), pCO2
37 (RR: 35–45mmhg), pO2 110 (RR: 85–100mmhg), and
bicarbonate 23 (RR: 22–26MEQ/L). His blood pressure
dropped (78/50mmhg) requiring intravenous dopamine.2 Case Reports in Medicine
Initial blood tests revealed a white blood cell count of 13.1
(RR: 4.5–11.0K/UL), aspartate transaminase of 233 (RR:
7–40IU/L), alanine transaminase of 88 (RR: 7–56IU/L),
troponin of 3.98 (RR: 0.0–0.05NG/ML), and remarkably
elevated CPK 3339 (RR: 22 to 198IU/L). The patient was
in acute renal failure with BUN 13 (RR: 8–20MG/DL),
creatinine of 3.2 (RR: 0.4–1.24MG/DL), and potassium of
6.6 (RR: 3.5–5.1MMOL/L). Urine toxicological screen was
positive for methadone and benzodiazepines, and negative
for amphetamines, barbiturates, cannabinoids, cocaine and
phencyclidine. His initial CSF exam showed protein 37.2
(15–40MG/DL), glucose 81 (RR: 40–75MG/DL), white cells
3(RR:0–5/UL),redcells1(RR:<1/UL),myelinbasicprotein
(MBP) 2.8 (RR: <1.5NG/ML), negative cultures, and no
oligoclonal bands. A CAT scan without contrast of the head
showed loss of distinction between grey and white matter.
Patient did not have an initial MRI. Coronary angiogram
revealed no abnormalities.
Despitenogrowthoncultures,hewasempiricallytreated
for possible aspiration pneumonia with intravenous antibi-
otics. He received kayexalate and intravascular hydration
along with sodium bicarbonate for acute renal failure. His
condition stabilized, and he was extubated after 2 days.
He gradually recovered over the next 4 days and was
subsequentlydischargedhomeafter6daysofhospitalization.
At discharge, he had no neurological deﬁcits, and he was able
to return to his previous profession as a computer engineer.
However, 2 weeks after discharge, his cognitive and
behavioral function began to deteriorate. He was brought
to the ED 34 days from initial presentation, for subacute
onset of diﬃculties with short-term memory, confusion,
impairment of executive function, and lack of motivation.
He was admitted to the psychiatry ward. At the time of the
second admission, he was alert and oriented to person only.
He was able to follow one-step commands. Cranial nerves
wereintact.Hewasmovingallhisextremitiesspontaneously.
He had positive grasp and palmomental reﬂexes and was
hyperreﬂexic with bilateral plantar extensor response. He
continued to deteriorate over the next few days to the point
he was totally dependent on others for all activities of daily
living.
CSF cytology, protein, cell counts, and glucose were
normal. Oligoclonal bands were not detected. MBP was 4.4
(RR: <1.5NG/ML). CSF 14-3-3 protein was negative. Urine
sulfatide, peripheral leukocyte arylsulfatase A assay, serum
longchainfattyacids,ELISAforHIV,serumlevelsofvitamin
B12, methylmalonic acid, folate, TSH, vitamin E level, and
thiamine were all within normal range. First EEG was done
46 days from initial presentation and showed symmetric
bihemispheric dysfunction, and second EEG done on day
60 showed well-developed dominant rhythm of 10 hertz
present mainly in the left hemisphere, marked depression of
alpha, and medium amplitude of 2-3 hertz waves in the right
frontotemporal regions, suggesting possible dysfunction of
the right hemisphere. There was no indication of epileptic
discharges.
MRI of the brain revealed diﬀuse abnormal T2 signal
in the corona radiata, centrum semiovale, and subcortical
white matter throughout all lobes. There was no abnormal
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Figure 1: Initial brain MRI illustrates diﬀuse abnormal T2 FLAIR
signal in the corona radiata, centrum semiovale, and subcortical
white matter throughout all lobes (a)–(c). Followup MRI brain at
2 months was unchanged (d)–(f).
contrast enhancement, and no foci of restricted diﬀusion
(Figure 1).
Initial brain biopsy was done 50 days from initial presen-
tation to evaluate forhypoxic encephalopathy, toxic leukoen-
cephlopathy, Creutzfeldt-Jakob disease, and metachromatic
leukodystrophy. It was nondiagnostic as there was no white
matter on the biopsy sample. A repeat biopsy of the right
frontal lobe 12 days later revealed white matter changes
including small vacuoles, axonal injury, diﬀuse reactive
astrogliosis, and microglial proliferation. Luxol fast blue
myelin stains revealed well-stained and preserved myelin.
Immunohistochemical stains revealed immunoreactivity of
axons in white matter area to b-APP and NF. White matter
also showed strong immunoreactivity with CD 68 and GFAP
(Figure 2).
A working diagnosis of DPHE was based on clinical
historyandneuroimagingﬁndings.Fifty-sixdaysfrominitial
presentation, he was treated with intravenous methylpred-
nisolone 500mg twice daily for 5 days, amantadine 100mg
twice a day, vitamin C 500mg twice a day, and vitamin E
800mg three times a day. Following 5 days of therapy, the
patient was more interactive and followed simple commands
like open your month and touch examiner’s ﬁnger. He
recognized his wife and regained some long-term memories.
He could again feed himself and used more words to interact
and speak. After 1 week, methylphenidate was added to
increase his participation in rehabilitation. Within 3 days
he began having visual hallucinations consisting of spider
webs and space ships around him. Both amantadine and
methylphenidate were stopped and the visual hallucinations
disappeared. He was able to perform his activities of daily





Figure 2: Cerebral cortex shows apparently normal neuronal
density ((a) hematoxylin and eosin, ×200 original magniﬁcations).
The histological changes in the biopsy center in the white matter
show increased cellularity with reactive gliosis ((b) hematoxylin
and eosin, ×400; (c) anti-GFAP, ×200), microglial activation ((d)
anti-CD68, ×200), and axonal changes, consistent with recent
axonal injury ((e) anti-neuroﬁlament, ×400; (f) anti-B-APP, ×200
all original magniﬁcations) in the presence of abundant well-
stained myelin ((g) luxol fast blue with hematoxylin and eosin,
×200). Ultrastructural evaluation conﬁrms axonal degeneration
with myelin preservation (h).
aslowtaperofprednisone 80mg,withincrementaldecreases
by 20mg every 2 weeks. He continued to show signiﬁcant
improvement during two weeks of inpatient rehabilitation
therapy. At the time of discharge, he was independent in
performing all activities of daily living and returned to his
job as a computer engineer. A repeat MRI after 2 months
was unchanged from his initial MRI (Figure 1). At 6-month
followup following hospital discharge, neuropsychiatric test-
ing revealed no deﬁcits. He was doing well at 2-year followup
clinic visit.
3. Discussion
DPHE is characterized by a delayed onset of neurologi-
cal deterioration after hypoxic-ischemic brain injury [1].
The diagnosis of DPHE is based on typical clinical and
radiological presentation, after excluding other conditions
that may mimic DPHE [7]. MRI or CT brain studies in
DPHE show diﬀuse periventricular white matter changes
[8]. Classic neuropathological ﬁndings in DPHE associated
with CO poisoning are characterized by diﬀuse symmetrical
demyelination in white matter with preserved axons, U
ﬁbers, and perivascular white matter [9]. Although MRI
b r a i ni no u rp a t i e n ts h o w e dd i ﬀuse white matter lesions,
surprisinglyhistopathologyshowedaxonalinjurywithintact
myelin structure. Pathological ﬁndings in our patient are
similar to those seen in toxic leukoencephlopathy including
small vacuoles in the white matter, axonal injury, diﬀuse
reactive astrogliosis, and microglial proliferation [10]. Dif-
ference in pathological changes in our patient indicates that
methadone induced DPHE may be diﬀerent in underlying
pathophysiology from CO-induced DPHE and DPHE may
represent a spectrum of disorders rather than a single clinical
entity.
Even though impaired oligodendroglial function [11],
reduced arylsulphatase A activity [12], altered immune
response [13], and mitochondrial dysfunction [14]h a v e
been postulated in the etiology of DPHE, the underlying
pathophysiology is unknown. In our patient, CSF MBP
increased with time (2.8NG/ML at initial presentation
to 4.4NG/ML at second admission) which may represent
slow progressive axonal destruction. Delayed neurological
symptoms after initial insult may be explained by this slow
axonal destruction.
Methadone induced DPHE may be related to mitochon-
drial dysfunction as described in heroin-induced leukoen-
cephlopathy. Mitochondrial dysfunction causing opioid
related leukoencephlopathy has been suggested by electron
microscopy, elevated lactate peak on magnetic resonance
spectroscopy,andtheclinicalimprovementfollowingantiox-
idant therapy in few patients [14, 15].
There are no available controlled treatment trials for
DPHE. Steroids have occasionally been used with some
improvement in treatment of DPHE in children [2, 4]. In
an animal study, dexamethasone was found to be eﬀective
in preventing histological brain damage and learning and
memory impairment caused by hypoxic-ischemic insult
[16].
Autoimmune response against MBP induced by alde-
hydes from lipid peroxidation [13] may play an important
role in the pathophysiology of DPHE which may explain the
success of methylprednisolone in our patient. Amantadine
100mg twice a day may be tried if patient does not respond
tointravenoussteroidsorifpatienthasprominentfeaturesof
apathy and abulia [3]. High-dose vitamin C, vitamin E, and4 Case Reports in Medicine
coenzyme Q10 may be tried for their possible antioxidant
eﬀects and role in mitochondrial disorders [12, 17]. Early
and continued vigorous rehabilitation plays a very vital role
in the management of these patients as seen in our patient
[14]. The recovery and permanent neurological impairment
from DPHE varies from series to series. Choi reported 75%
fullrecoveryin1year,andShillitoandDrinkerreportedonly
50% full recovery within 2 years [1, 18]. Follow up MRI
at 2 months was unchanged in our patient despite clinical
improvement which goes along with a previous report
of earlier clinical improvement and delayed improvement
radiologically which may take up to 9 months [8]. As our
patient was doing extremely well at 2-year follow up, we
did not repeat his MRI brain although it would have been
interesting to follow the progression of white matter lesions.
The usage of methadone has increased signiﬁcantly dur-
ing the last decade with methadone-related deaths increas-
ing 390% from 1999 to 2004 [19]. However, despite the
widespread use of methadone and unintentional overdose
on methadone, only 5 cases of methadone induced DPHE
have been reported to date [2–6], suggesting that it is either
uncommon or often goes unrecognized or unreported. Out
of the 5 cases 4 were reported in children and only 1 was
reported in a 24-year-old male. We expect that more DPHE
cases will be seen with the widespread usage of methadone
in pain clinics. Neurobehavioral changes may be the initial
manifestation of DPHE. Clinicians, especially psychiatrists,
ER clinicians, and neurologists, should be fully aware of this
entity to avoid exposing the patient to extensive invasive
diagnostic procedures. The diagnosis of DPHE can be made
based on typical clinical presentation and neuroimaging
ﬁndings without brain biopsy. Patients with DPHE should
be considered for a trial of steroids with high doses of
antioxidant in order to hasten clinical recovery.
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